Senner Christopher J. 4
4 · EXELIXIS, INC. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Exelixis (EXEL) CFO Christopher Senner Sells Shares
What Happened
Christopher J. Senner, EVP and Chief Financial Officer of Exelixis, sold a total of 100,765 shares of Exelixis common stock in mid‑February 2026 across three dispositions: 34,278 shares on Feb 13 at $43.00 ($1,473,954), 35,870 shares on Feb 15 at a weighted average $43.92 ($1,575,410), and 30,617 shares on Feb 17 at a weighted average $43.67 ($1,337,044). Total proceeds across the three transactions were roughly $4.39 million. These were sales/dispositions (not purchases).
Key Details
- Dates & prices:
- Feb 13, 2026 — 34,278 shares sold at $43.00 (F1: multiple sales at $43.00–$43.04; weighted avg reported).
- Feb 15, 2026 — 35,870 shares disposed at $43.92 (code F: payment of exercise price or tax liability).
- Feb 17, 2026 — 30,617 shares sold at $43.67 (F4: multiple sales at $43.66–$43.78; weighted avg reported).
- Total shares sold: 100,765; total proceeds ≈ $4,386,408.
- Holdings after report: Filing notes 427,690 shares issuable upon vesting of RSUs/PSUs (One‑Time Award PSUs) (F2); it also references shares withheld to satisfy taxes on prior performance RSUs (F3) and Exelixis 401(k) plan shares (F5). The filing excerpt provided does not state a single net “shares owned after” total.
- Notable footnotes:
- F1/F4: weighted average sale prices; multiple transactions within the listed price ranges.
- F2: 427,690 RSUs/PSUs to be issued upon vesting from a March 31, 2025 award.
- F3: shares withheld to satisfy taxes related to performance RSUs awarded March 4, 2022 (performance certified Jan 16, 2025).
- F5: includes shares held under the company 401(k) plan.
- Timeliness: The report was filed Feb 18, 2026 for transactions occurring Feb 13–17, 2026. Because Form 4s are generally due within two business days of a transaction, the Feb 13 sale may have been reported later than the typical 2‑business‑day window (see filing for details).
Context
- Transaction code F indicates shares were disposed to satisfy an exercise price or tax liability (i.e., shares surrendered/withheld), while S indicates open‑market sales. Part of the activity appears to be routine tax‑related withholding rather than a straight cash‑raise sale.
- Sales by officers are common and do not by themselves signal company prospects; purchases generally carry more direct bullish signal for retail investors. This summary is factual and does not speculate on motivations.
Insider Transaction Report
Form 4
EXELIXIS, INC.EXEL
Senner Christopher J.
EVP and CFO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-13$43.00/sh−34,278$1,473,954→ 1,042,579 total - Tax Payment
Common Stock
[F3][F2]2026-02-15$43.92/sh−35,870$1,575,410→ 1,006,709 total - Sale
Common Stock
[F4][F2]2026-02-17$43.67/sh−30,617$1,337,044→ 976,092 total
Holdings
- 2,723(indirect: By 401(k))
Common Stock
[F5]
Footnotes (5)
- [F1]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
- [F2]Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
- [F3]Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
- [F4]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
- [F5]Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.
Signature
/s/ Nina Ayer, Attorney in Fact|2026-02-18